Skip to main content

Table 1 Dosages of SMC and anthelminthic drugs to be used in this study

From: Safety and effectiveness of delivering mass drug administration for helminths through the seasonal malaria chemoprevention platform among Senegalese children: study protocol for a randomised controlled trial

SP tablet (500mg + 25mg)

 • Children aged 12–59 months will receive a full tablet as a single dose on the first day

 • Children aged 5–10 years will receive one and a half tablet as a single dose on the first day

 • Children aged 11–14 years will receive two tablets as a single dose on the first day

AQ tablet (153mg base)

 • Children aged 12–59 months will receive a full tablet as a single daily dose for 3 consecutive days

 • Children aged 5–10 years will receive one and a half tablet as a single dose for 3 consecutive days

 • Children aged 11–14 years will receive two tablets as a single dose for 3 consecutive days

ALB tablet (200 or 400 mg depending on age)

 • Children aged 12–24 months will receive a half dose of albendazole 200mg

 • Children aged greater than 2 years and up to 14 years will receive a single dose of albendazole 400mg

PZQ tablet (40 mg/kg)

 • Children aged 1–14 years will receive praziquantel based on their body weight 40mg/kg